Effect of Anemia on Prognosis of Patients with Advanced Gastric Cancer

ZHANG Shu,LU Ming,LI Yan,LI Jie,SHEN Lin
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2015.09.013
2015-01-01
Abstract:OBJECTIVE To evaluate the impact of anemia on the overall survival in patients with advanced gastric cancer.METHODS 504 patients with advanced gastric cancer,who were categorized into three groups:normal group(normal Hb),mild-moderate group(6.5g/dl to normal Hb)and severe group(lower than 6.5g/dl Hb),were selected for survival analysis,and their baseline hemoglobin level and other factors were analyzed.The patients Kaplan-Meier survival curves with log rank test were used in univariate analysis while Cox's proportional hazard model was recruited for multivariate analysis.RESULTS The median overall survival was 10.4(8.9-11.8)months for all patients.Their mean baseline hemoglobin level was 112g/L.Nearly fifty-seven percent of patients had anemia and they had a lower median overall survival of 8.2(6.3-10.1)months compared with 12.4(9.0-15.9)months in non-anemia patients(P=0.003).One-year,two-year and three-year overall survival rates in anemic patients were 36.9%(106/287),17.1%(49/287)and10.1%(29/287),which were lower than that of non-anaemic patients [one-year for 50.2%(109/217),two-year for22.1%(48/217),three-year for 16.1%(35/217)],respectively.Moreover,patients with severe anemia had a 6.2months of median overall survival,which was significantly shorter than that of patients with mild-moderate anemia(9.3months,P=0.012)and non-anemia patients(12.4months P0.001).The patients with mild-moderate anemia showed significantly shorter overall survival(9.3months)than that(12.4months)of patients with normal Hb(P=0.012),as well as the severe anemia patients(6.2 months,P0.001).The multivariate analysis showed anemia(HR=1.37,95%CI:1.01-1.83,P=0.037)to be statistically independent prognostic factor for overall survival.CONCLUSIONS Our data suggested that the baseline anemia was an independent negative prognostic factor for overall survival and a lower hemoglobin level might predict for a poorer overall survival in patients with advanced gastric cancer.
What problem does this paper attempt to address?